Still, no matter how forward-thinking they were, in the early 1960s, they were the mainstream. That is until a conceptual artist by the name of Yoko Ono stepped into their lives. Now, as an artist, ...

AstraZeneca is buying out its roxadustat partner FibroGen in China. Ono Pharmaceutical's $2.4 billion Deciphera acquisition has borne fruit. And more. 1. Novo Nordisk to sue KBP Biosciences over ...

The film features remastered audio overseen by Sean Ono Lennon, the couple’s son. The doc reconstructs the couple’s Greenwich Village apartment to paint a picture of their American experience ...

Legendary artist and musician Yoko Ono turns 92 today, on February 18, although will likely be celebrating her big day privately as she has for years. The Japanese icon, best known for her ...

At that time, Lennon was married to the renowned Japanese artist Yoko Ono, who turns 92 today (Tuesday, February 18), and they had a son, Sean Lennon. For almost four decades, Ono refrained from ...

An Ono Pharma drug for a type of tumor affecting tissues of the joints is now FDA approved, giving the Japanese company a product with dosing and safety advantages over the Daiichi Sankyo product ...

Yoko Ono (Japanese: 小野 洋子, Ono Yōko, オノ・ヨーコ; born February 18, 1933) is a Japanese multimedia artist, singer, songwriter, and peace activist. Her work also encompasses performance art and filmmaking.

Do you want to contact Yoko Ono? Get all the essential Yoko Ono contacts so you can get in touch with them about any business opportunities, events and more. We will give you Yoko Ono's email address, ...

The former MP also compared Meghan to Yoko Ono - who has previously been accused of being the person to break up the Beatles, after the band split up one year after she married John Lennon.

Sean Ono Lennon has insisted that it is "not a burden" to have famous parents. The 49-year-old musician is the son of Beatles legend John Lennon - who was assassinated in 1980 at the age of 40 - and ...

Fellow Japanese drugmaker Ono Pharmaceutical has won an FDA green light for vimseltinib to treat adult patients with symptomatic tenosynovial giant cell tumor (TGCT), which is typically ...